This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable NSCLC based on positive overall survival results
First and only long-acting C5 complement inhibitor offers patients with AQP4 Ab+
WINREVAIR is a breakthrough biologic for this rare, progressive disease
The pilot plant is focused on scaling up beverage production and will support applications
The plan essentially was to separate Aster’s India and GCC businesses to unlock long-term value
Versavo is the first Dr. Reddy's biosimilar product to be approved and launched in the UK
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older
Grand opening of the joint venture between Evonik China and Shandong Vland Biotech in Qingdao, China
More than 10,000 scientific publications containing EUDRAGIT
Subscribe To Our Newsletter & Stay Updated
